GNH USA

Europe — EMA

Olmesartan Medoxomil/Amlodipină Accord (Olmesartan Medoxomil, Amlodipine)

GNH USA supplies Olmesartan Medoxomil/Amlodipine Accord (Olmesartan, Amlodipine), a antihypertensive for hypertension. Request a quote for global supply.

Olmesartan Medoxomil, Amlodipine

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan Medoxomil and Amlodipine, the active ingredients in Olmesartan Medoxomil/Amlodipine Accord, are antihypertensive agents presented as an oral tablet for oral use. They work together to lower elevated blood pressure in adult patients with hypertension. The combination exploits complementary mechanisms: olmesartan blocks the angiotensin II type 1 receptor, while amlodipine relaxes vascular smooth muscle via calcium‑channel inhibition, providing synergistic blood‑pressure control.

GNH USA supplies Olmesartan Medoxomil/Amlodipine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Olmesartan/Amlodipine is indicated for the management of hypertension, a condition characterized by chronically elevated arterial pressure.

Hypertension: reduces systolic and diastolic blood pressure and lowers cardiovascular risk. Essential hypertension: provides effective blood‑pressure control when monotherapy is insufficient. High blood pressure: improves long‑term outcomes by maintaining target blood‑pressure levels.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

The combination may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness - Headache - Peripheral edema - Flushing - Fatigue - Palpitations

Serious or Rare Side Effects: - Angioedema - Severe hypotension - Myocardial infarction - Hepatic dysfunction - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Rhabdomyolysis

What precautions apply to Olmesartan Medoxomil, Amlodipine?

When prescribing Olmesartan/Amlodipine, clinicians should observe several safety considerations.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal or hepatic impairment: dose may need adjustment and patients require close observation. - Pregnancy: contraindicated in pregnancy (Category D) due to risk of fetal toxicity. - Lactation: avoid use while breastfeeding because drug may be excreted in milk. - Elderly patients: start at lower dose and monitor for orthostatic effects. - Store at below 25°C: keep in original packaging, protect from moisture and light.

What does Olmesartan Medoxomil, Amlodipine interact with?

Olmesartan/Amlodipine can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients: may increase risk of renal impairment and hyperkalemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can raise amlodipine plasma levels, leading to hypotension. - Other antihypertensives (e.g., ACE inhibitors, beta‑blockers) used together: may cause additive blood‑pressure lowering. - Lithium therapy: olmesartan may increase lithium concentrations, risking toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce amlodipine exposure, decreasing efficacy. - Diuretics: can enhance antihypertensive response, requiring blood‑pressure checks. - Beta‑blockers: combined use may increase risk of bradycardia. - ACE inhibitors or ARBs: monitor potassium levels for hyperkalemia. - Grapefruit juice: may modestly increase amlodipine concentrations.

Frequently asked questions

What is Olmesartan Medoxomil/Amlodipine Accord used for?+
Olmesartan Medoxomil/Amlodipine Accord is a fixed‑dose combination indicated for the treatment of hypertension. It is prescribed to adults whose blood pressure remains uncontrolled with monotherapy, helping to achieve target systolic and diastolic pressures and reduce cardiovascular risk.
How does Olmesartan Medoxomil work?+
Olmesartan Medoxomil is an angiotensin II type 1 (AT1) receptor blocker. By selectively binding to AT1 receptors, it prevents angiotensin‑II‑induced vasoconstriction and aldosterone secretion, leading to vasodilation, reduced sodium retention, and lower blood pressure.
How does Amlodipine work?+
Amlodipine is a long‑acting calcium‑channel blocker that inhibits L‑type calcium channels in vascular smooth‑muscle cells. This inhibition reduces calcium influx, causing arterial smooth‑muscle relaxation, vasodilation, and a subsequent decrease in peripheral vascular resistance and blood pressure.
What determines the prescribed dose of this medication?+
The dose of Olmesartan Medoxomil/Amlodipine is individualized by the prescribing clinician based on factors such as the patient’s baseline blood‑pressure level, response to therapy, renal and hepatic function, and any concomitant antihypertensive agents.
Is Olmesartan Medoxomil/Amlodipine safe during pregnancy or breastfeeding?+
Olmesartan Medoxomil/Amlodipine is classified as pregnancy Category D, indicating evidence of fetal risk, and it is contraindicated during pregnancy. Use while breastfeeding is also discouraged because the drugs may be excreted in milk and could affect the infant.
How do I order Olmesartan Medoxomil/Amlodipine Accord from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this combination compare with other antihypertensive therapies?+
The Olmesartan/Amlodipine combo merges an angiotensin‑II receptor blocker with a calcium‑channel blocker, offering additive blood‑pressure reduction and better tolerability than high‑dose monotherapy. Compared with single‑class agents, it often achieves target pressures with fewer pills and may reduce the need for additional drugs.
What are the recommended storage conditions for this product?+
Store the tablets at temperatures below 25 °C in their original packaging. Protect them from excess moisture, light, and humidity to maintain potency throughout the shelf‑life.
How should the medication be taken?+
Olmesartan Medoxomil/Amlodipine is taken orally, usually once daily, with or without food. Patients should follow the prescriber’s instructions, swallow the tablet whole, and avoid crushing or chewing it.
What are the most serious adverse reactions to monitor?+
Serious reactions include angioedema, severe hypotension, myocardial infarction, hepatic dysfunction, severe allergic responses such as Stevens‑Johnson syndrome, and rhabdomyolysis. Patients should seek immediate medical attention if they experience swelling of the face or throat, sudden weakness, chest pain, or unexplained muscle pain.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Accord Healthcare Polska Sp. Z O.O.
Origin
EU

Related products

Albis

Albis

Olmesartan Medoxomil, Amlodipine

Laboratorios Alter, S.A.
EU
Almacor Duo

Almacor Duo

Olmesartan Medoxomil, Amlodipine

Antibiotice Sa
EU
Alsamod

Alsamod

Olmesartan Medoxomil, Amlodipine

Krka, D.D., Novo Mesto
EU
Amelior

Amelior

Olmesartan Medoxomil, Amlodipine

Menarini International Operations Luxembourg S.A.
EU